Short answer: Current studies have not shown that TRT raises prostate cancer risk in carefully screened men. That does not prove lifelong safety or make TRT right for everyone. Prostate screening before treatment and follow-up during treatment depend on your age, history, symptoms, and test results.
PSA stands for prostate-specific antigen, a protein made by the prostate. A PSA blood test cannot diagnose cancer by itself. Your clinician also considers your age, family history, urinary symptoms, exam findings, and past results. Some findings need a urologist, a specialist in urinary and male reproductive health.
1. Testosterone supports normal prostate biology
The prostate responds to testosterone and DHT, a hormone the body makes from testosterone. These hormones help support normal prostate growth and function. This link is one reason clinicians check prostate health when considering TRT.
In the TRAVERSE trial, prostate cancer and other major prostate problems were uncommon and did not differ significantly between the testosterone-gel and placebo groups. The study screened out men at high prostate-cancer risk. These results are reassuring, but they do not settle the long-term risk for every patient.
2. Screening starts before the first dose
Before TRT, your clinician asks about past prostate cancer, urinary symptoms, family history, and earlier PSA tests. Together, you decide whether a PSA test or prostate exam is needed based on your age and risk.
The Endocrine Society’s 2018 guideline advises against starting TRT in men with known prostate cancer or an unexplained prostate lump. It also calls for a urology review before TRT when PSA is above 4.0 ng/mL, or above 3.0 ng/mL in a man at higher cancer risk. An abnormal PSA does not mean cancer, but it needs review.
A 2026 labeling update: In June 2026, HHS announced FDA-requested changes to testosterone labels. The proposed prostate-cancer restriction would focus on cancer that has spread to other parts of the body. This announcement does not show that every product label has changed. Screening and monitoring still matter, and men with current or past prostate cancer need a specialist-led decision.
3. PSA can change for reasons other than cancer
An enlarged prostate, infection, inflammation, recent urinary procedures, or ejaculation can raise PSA. A high result needs context. Tell the clinician about symptoms and anything that may have affected the test.
Your past results help show what has changed. An unexpected rise may need a repeat test before deciding on further testing. Review symptoms and test timing with your clinician.
4. Follow-up is part of safe TRT
Follow-up checks whether treatment helps and whether it causes side effects. It may include symptoms, testosterone, blood pressure, and hematocrit, the share of blood made up of red blood cells. Prostate checks depend on your age, risk, and the screening plan you choose with your clinician.
During the first year of TRT, the Endocrine Society advises a urology review for a confirmed PSA rise of more than 1.4 ng/mL above the starting value, a confirmed PSA above 4.0 ng/mL, or an abnormal prostate exam. These are reasons for further testing, not a cancer diagnosis.
Our TRT lab monitoring guide explains why follow-up timing depends on the type of treatment and your health.
5. Urinary symptoms should be discussed
An enlarged prostate is called benign prostatic hyperplasia, or BPH. It is not cancer. BPH can cause a weak urine stream, a sudden urge to urinate, trouble starting, or waking at night to urinate. Severe symptoms need an evaluation before TRT.
Studies in screened men have not shown a clear worsening of mild to moderate urinary symptoms with TRT. Evidence is more limited for severe symptoms. Seek urgent care if you cannot urinate. Blood in the urine, painful urination, fever, or a rapid change in symptoms also needs prompt medical attention.
6. Risk is personal
Prostate cancer risk rises with age. Risk is also higher if your father or brother had it, especially at a young age. Black men have higher rates of prostate cancer and death from it. These factors can affect when to start screening and how often to check.
Decide with your clinician whether PSA screening makes sense for you. It can find a cancer that needs treatment. It can also cause false alarms or find a slow-growing cancer that would never have caused harm. Those findings may lead to more tests, a biopsy, or treatment.
7. More testosterone is not better
The goal of TRT is to treat confirmed low testosterone and bring levels into a healthy range. Raising the dose without a clear need can add side effects without improving symptoms.
If symptoms continue despite a healthy testosterone level, your clinician may review other causes. Sleep problems, depression, thyroid disease, anemia, medicines, or heart health may matter. Our guide to low testosterone symptoms explains why symptoms alone are not enough for a diagnosis.
What if you have a history of prostate cancer?
Talk with the urologist or cancer specialist who treated you. Some men treated for cancer that had not spread may be considered for TRT, but the evidence and timing vary. This needs an individual plan and careful follow-up. A general label update does not decide what is safe for you.
What should you report during treatment?
- New trouble starting urine or emptying the bladder.
- Blood in the urine or semen.
- New pelvic or bone pain.
- Fever with urinary symptoms.
- A major change in urinary frequency or nighttime urination.
- Any abnormal PSA result from another clinic.
These symptoms do not always mean cancer, but they need a review. Also discuss plans for children: TRT can lower sperm production. Our guide to TRT and fertility explains this risk.
Frequently asked questions
Does TRT cause prostate cancer?
Studies in carefully screened men have not shown a clear rise in prostate cancer with TRT. Long-term questions remain. Testing before treatment and follow-up still matter.
What PSA level is too high for TRT?
The Endocrine Society advises a urology review before TRT if PSA is above 4.0 ng/mL, or above 3.0 ng/mL in a man at higher risk. These numbers do not diagnose cancer.
Can TRT make an enlarged prostate worse?
Studies have not shown clear worsening of mild to moderate symptoms in screened men. Severe symptoms need review before treatment, and new symptoms should be reported.
How often is PSA checked on TRT?
Timing depends on your age, risk, past results, and the screening plan you choose. For men who choose prostate monitoring, the Endocrine Society suggests a check 3 to 12 months after starting TRT. After the first year, routine screening guidance helps set the plan.
This article is for general educational purposes and does not replace individualized prostate cancer screening or medical advice. TRT requires a confirmed diagnosis, prescription, and ongoing follow-up.
